Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patientsVancheswaran Gopalakrishnan, Jennifer A. Wargo|Science|2017Cited by 4.6k
B cells and tertiary lymphoid structures promote immunotherapy responseBeth A. Helmink, Jennifer A. Wargo|Nature|2020Cited by 2.6k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Keren Yizhak et al.|Cell|2018Cited by 2k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T. Geller, Ravid Straussman, Michal Barzily-Rokni et al.|Science|2017Cited by 1.8k
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Todd R. Golub, Teppei Morikawa et al.|Nature|2012Cited by 1.7k